 |
|
Secondary renal tubular dysgenesis in a newborn exposed to angiotensin Ⅱ receptor antagonist during gestation
Mi Hyeon Gang, Yong Wook Lee, Mea-young Chang
Clin Exp Pediatr. 2021;64(3):136-138. Published online 2020 Jul 21 DOI: https://doi.org/10.3345/cep.2020.00752
|
|
Citations to this article as recorded by
 Practical Approach to Congenital Anomalies of the Kidneys: Focus on Anomalies With Insufficient or Abnormal Nephron Development: Renal Dysplasia, Renal Hypoplasia, and Renal Tubular Dysgenesis
Alexia Gazeu, Sophie Collardeau-Frachon
Pediatric and Developmental Pathology.2024; 27(5): 459. CrossRef Angiotensin receptor blocker induced fetopathy: two case reports and literature review
Jinwoon Joung, Heeyeon Cho
Childhood Kidney Diseases.2023; 27(2): 121. CrossRef Sustained activation of the renin–angiotensin–aldosteron system after fetal exposure to AT1 blockers: Effects on kidney and bone in a preterm newborn
Gabriele D'Amato, Georgios Rembouskos, Rosa Cafagna, Domenico Dentico, Stefano Palladino, Mariangela Chiarito, Maria Felicia Faienza
Journal of Obstetrics and Gynaecology Research.2022; 48(12): 3331. CrossRef Inhibition of the renin-angiotensin system during fetal kidney development
Eujin Park
Clinical and Experimental Pediatrics.2021; 64(3): 121. CrossRef Multiple drugs
Reactions Weekly.2021; 1877(1): 289. CrossRef
|